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Abstract
Gastrointestinal (GI) bleeding due to colonic angiodysplasias can be associated with calcifying
aortic stenosis (AS). GI angiodysplasias and AS are defined as chronic degenerative disorders,
and the prevalence of both diseases increases with age. Moreover, degenerative AS is associated
with increased destruction of high molecular weight multimers of von Willebrand factor which
can promote bleeding from intestinal angiodysplasias. The coincidence of gastrointestinal bleed-
ing angiodysplasias and AS has been known for many years as Heyde’s syndrome. Aortic valve
replacement is the first line therapy for advanced stage AS-patients, but can also be an effective
treatment for co-existent bleeding angiodysplasias and acquired von Willebrand disease.
In this study, we tried to collect as well as systemized data about the etiopathogenesis of AS
coagulation abnormalities and diagnostic, clinical and therapeutic implications of AS-patient
with GI angiodysplasias. (Cardiol J 2010; 17, 4: 330–334)
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Introduction
Aortic stenosis (AS) can be complicated by
coagulation abnormalities. The commonest and best
documented clinical manifestation is hemorrhagic
tendency, such as gastrointestinal (GI) [1, 2] and
nasal bleeding [3, 4]. Bleeding from the GI system
usually occurs in elderly patients with co-existent
GI angiodysplasias. An association between AS and
GI bleeding was first suggested in 1958 by Edward
J. Heyde, an internist working in Vancouver. He
noted (in a letter to the New England Journal of
Medicine) ten cases of coincidence between calci-
fying AS and GI bleeding of obscure origin [5]. GI
bleeding angiodysplasia with co-existent autopsy-
-proven AS was first corroborated in 1971 by Boss
and Rosenblum [6]. The hypothesis of association
between degenerative AS and GI bleeding due to
colonic angiodysplasia was confirmed by further
studies and has been termed Heyde’s syndrome
(HS). Warkentin et al. [7] suggested that GI bleed-
ing angiodysplasia in AS-patients is caused by ac-
quired type 2A von Willebrand disease (vWD-2A),
characterized by decreased level of high molecular
weight (HMW) von Willebrand factor (vWF) multi-
mers. Recent research confirmed this etiology of
the HS phenomenon (Fig. 1) [7–9].
Prevalence
AS is the commonest valvular heart defect and
affects 3–5% of the population aged 65 and over [10,
11]. But, the prevalence of AS in patients with
bleeding from colonic angiodysplasia is still unde-
fined and controversial. The incidence of GI bleed-
ing in the general population is about 0.9% [12].
According to different sources, between 7–29% [13,
14] of patients with diagnosed GI bleeding angio-
dysplasias suffer from AS or aortic sclerosis, and
3% of advanced AS-patients have GI bleeding [12].
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On the other hand, one study showed no relation
between AS and GI bleeding [15].
Association between degenerative aortic
stenosis and von Willebrand disease
Von Willebrand factor
Von Willebrand factor (vWF) is a multimeric
glycoprotein (20,000 kD) that circulates in blood
plasma and binds to coagulation factor VIII in a non-
-covalent complex. vWF is produced constitutively
in endothelium (in the Weibel-Palade bodies),
megakaryocytes (a-granules of platelets), and sub-
endothelial connective tissue. vWF plays a role in
primary hemostasis and helps in the proper adhe-
sion of platelets to the exposed subendothelium due
to damage occurring to the blood vessels [16]. In
forming thrombus, and during normal wear, large
multimers of vWF are cut by plasma vWF-cleaved
metalloprotease called ADAMTS 13 (a disintegrin
and metalloprotease with thrombospondin type 1
motifs) [17].
Acquired type 2A von Willebrand disease
as a consequence of high shear stress
In AS-patients, HMW von Willebrand factor
multimers, normally circulating in plasma, are sub-
ject to high fluid shear stress presented in nar-
rowed aortic valve [18]. During passing stenotic
aortic valve, under conditions of high shear stress,
large multimers of vWF are subject to increased
exposure of ADAMTS 13 [19, 20]. High shear
stress changes the structure of vWF and makes it
more prone to proteolysis. The effect of increased
vWF proteolysis is depletion of HMW multimers
that are the most hemostatically important in pri-
mary hemostasis. There is significant dependence
between numbers of HMW multimers and aortic
valve gradient (AVG) [21]. Decreased number of
HMW von Willebrand multimers is a laboratory
manifestation of acquired vWD-2A.
Acquired depletion of HMW multimers, also
called von Willebrand syndrome type 2A (vWS-2A),
can be a result of many other disorders. The com-
monest reasons for vWS-2A are shown in Table 1.
Laboratory manifestations of vWS-2A
Loss of HMW vWF multimers is a basic labo-
ratory manifestation of acquired vWD-2A in patients
suffering from AS. Electrophoretic analysis of vWF
multimers is the method of choice [26]. Prolonged
bleeding time, decreased ristocein co-factor activity
(vWF:RCo), and decreased vWF antigen (vWF:Ag)
are also common laboratory symptoms of vWD-2A
and can be useful in the diagnostic process [27].
Moreover, a lower level of vWF:RCo than vWF:Ag
is characteristic for most patients with  vWD-2A
[27]. However, partial thromboplastin time is usu-
ally normal and factor VIII level is often not low-
ered [26]. HMW multimers are markedly lowered
even in subtle form of vWD-2A with normal results
of skin bleeding time, vWF:RCo and vWF:Ag [27].
Figure 1. Pathogenesis of Heyde’s syndrome.
Table 1. Commonest disorders causing
von Willebrand syndrome type 2A [9, 22–25].
Degenerative aortic stenosis
Hypertrophic cardiomyopathy
with left ventricular outflow
tract obstruction
Ventricular septal defect
Patent ductus arteriosus
Immunologic disorders (systemic lupus
erythematosus, scleroderma, mixed
connective tissue disease, diabetes mellitus)
Acute leukemia and non-hematologic
neoplasms
Drugs (hydroxyethyl starch, ciprofloxacin,
griseofulvin, valproic acid, recombinant factor VIII)
Monoclonal gammopathies
Uremia
Renal insufficiency
Cirrhosis of the liver
Pulmonary hypertension
Cardiovascular
diseases
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Aortic stenosis and angiodysplasia
Angiodysplasia is a mucosal and submucosal
vascular malformation that occurs typically in a co-
lon. Histologically, it is similar to teleangiectasia
and is formed by enlarged and fragile vessels. The
typical location for angiodysplastic changes is the
right side of the colon (cecum and ascending colon)
but it can also occur in the stomach and the small
intestine [28]. Other locations of bleeding angio-
dysplasias like nasal mucosa have also been de-
scribed [4]. Colonic angiodysplasia can be found in
1–6% of patients admitted to the hospital with GI
bleeding symptoms [29, 30]. Depletion of HMW
multimers of vWF in AS (vWS-2A) increases risk
of bleeding from co-existent angiodysplasia [7, 22].
Degenerative process as a causative factor
of angiodysplasia and aortic stenosis
The degenerative age-related process plays
a major role in forming GI angiodysplasia [31]. The
same process is a main etiology of calcifying AS
(degenerative AS, age-related AS) [32] and con-
nects these two disorders. Angiodysplasia and de-
generative AS typically appear in advanced age.
Hypoxemic theory
Narrowed aortic valve decreases perfusion in
the GI tract, causes hypoxemia and is the main rea-
son for persistent vasodilatation in GI mucosa. Per-
manent dilatation of GI vessels promotes intesti-
nal angiodysplasias [33].
Genetic predisposition
Other factors like genetic predisposition may also
result in colonic angiodysplasias and calcifying AS [31].
Congenital connective tissue disorders can intensify
the degenerative process in colonic connective tissue
and accelerate the age-related degeneration process in
the aortic valve (congenital bicuspid aortic valve) [34].
Investigation for angiodysplasia
The investigation of intestinal angiodysplasia
is still imperfect because malformed vessels may
sometimes be very tiny and impossible to detect,
hence some patients may be under-diagnosed. How-
ever, selective angiography of mesenteric arteries
is recommended as a ‘gold standard’ (Fig. 2) [29].
One limitation of this procedure is that it has to be
performed during an episode of bleeding, otherwise
it is not reliable. Angiodysplastic lesions can also
be identified via colonoscopy (Fig. 3) but some pa-
tients with GI bleeding who are diagnosed with an-
giodysplasia show a normal result to this procedure
[28, 29, 35]. Other investigations that can help dia-
gnose angiodysplasia include capsule enteroscopy
and double-balloon enteroscopy, both of these fa-
cilitate visualization of the small intestine [36], la-
beled red blood cell scintigraphy and endoscopic
Doppler sonography.
Figure 2. Selective angiography of superior mesenteric
artery. Multiple areas of small angiodysplasias localized
at cecum and ascending colon (http://www.eurorad.
org/eurorad/case.php?id=7814).
Figure 3. Colonoscopic view of gastrointestinal angiody-
splasias (http://www.gihealth.com/html/education/photo/
/colonAngiodysplasia.html).
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Management of Heyde’s syndrome
Aortic valve replacement as
a treatment of choice
There are many methods of HS therapy. How-
ever, aortic valve replacement (AVR) should be
recommended as a ‘gold standard’ [37, 38]. It is
proven that AVR corrects the blood supply in the
gut. Moreover, decreased number of HMV vWF
multimers undergoes normalization after valve re-
placement [39]. It is reported that 95% of AS-pa-
tients with GI bleeding due to angiodysplasia have
no bleeding symptoms after AVR [40]. Replacement
with biologic prosthesis is recommended as the first
line treatment for AS-patients with co-existent gas-
trointestinal bleeding [41]. Patients with a replaced
mechanical valve should take anticoagulants, which
would increase angiodysplasias bleeding [42].
Other treatment options for angiodysplasia
Another (though less effective) management
method for GI angiodysplasia is endoscopy including
laser photocoagulation, sclerotherapy and electroco-
agulation [43]. Selective embolization during mesen-
teric angiography can be useful in patients with se-
vere bleeding lesions and can be an alternative to
surgical treatment [44, 45]. Laparotomy and gas-
trointestinal surgery in the form of segmental bowel
resection or blind right colectomy is recommended
in some cases [46]. There have been positive reports
of systemic treatment in GI bleeding angiodysplasia.
Hormonal therapy including small doses of ethinyl
estradiol [47], progesterone, somastatin [48] and long-
-acting octreotid [49] can help control bleeding. Tha-
lidomide, oral iron, antifibrinolytics, and vWF/factor
VII (FVIII) concentrate [45, 50] have also been report-
ed as treatment methods for GI angiodysplasias.
Conclusions
Calcifying aortic stenosis can be complicated by
GI bleeding which is linked to colonic angiodyspla-
sia. Co-existent type-2A von Willebrand syndrome
in AS-patients promotes hemorrhagic tendency from
angiodysplasias. Both of these disorders, calcifying
AS and angiodysplasias, appear in elderly patients
and are promoted by age-related degenerative pro-
cess. Episodes of GI bleeding may become danger-
ous and problematic, especially in elderly patients,
and may complicate the diagnostic and therapeutic
process. It is very important to know that HS in the
form of both its components can be efficiently cured
by one valve replacement therapy.
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